National Medical Products Administration (NMPA) conducted BNV Biolab’s WMPF Complex safety tests.


National Medical Products Administration (NMPA) conducted BNV Biolab’s WMPF Complex product safety tests.

The tests included 1. Microbial bacterial detection 2. Heavy metal toxicity test 3.Skin sensitization and irritation test. The tests uniformly disclosed significant results indicating products’ pharmaceutical level of safety.



Bacteria, yeast, E.coli, staphylococcus aureus and pseudomonad tests all showed significantly clear results of BNV Biolab’s product.



Heavy metals toxicity test testing for mercury, ainc, arsenic, cadmium and dioxane also revealed non-toxic results for BNV Biolab’s product.




Repeated skin sensitization and irritation test showed no sensitization nor irritation on the subjects' skin. Compared to the control, BNV Biolab’s product did not show any signs of erythema nor swelling of the skin.

NMPA  conducted safety tests of BNV Biolab’s products all acknowledged product safety and above average quality of the products. 

Through the test results, BNV Biolab’s products' pharmaceutical level of ingredients and manufacturing system had been proven.


Copyright 2021. BNV Biolab Co., Ltd. All rights reserved. Address  5, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea 08594 Tel  (+822) 3452 0230